<?xml version='1.0' encoding='utf-8'?>
<document id="25151726"><sentence text="[The drug-drug interaction mediated by efflux transporters and CYP450 enzymes]." /><sentence text="Multidrug regimens and corresponding drug interactions cause many adverse reactions and treatment failures" /><sentence text=" Drug efflux transporters: P-glycoprotein (P-gp), multidrug resistance associated protein (MRP) and breast cancer resistance protein (BCRP) in conjunction with metabolizing enzymes (cytochrome P450, CYP450) are major factors in such interaction" /><sentence text=" In recent years, a large number of studies have shown that P-gp plays a role in the oxidative metabolism of its substrates that are also substrates of CYP3A4" /><sentence text=" Combined actions of P-gp and CYP3A could account in some part for the low oral bioavailability determined for many of these dual substrates" /><sentence text=" P-gp along with efflux transporters (MRP and BCRP) having overlapping substrate specificity plays critical role in drug disposition" /><sentence text=" The relationship between MRP or BCRP and CYP3A is similar to that between P-gp and CYP3A" /><sentence text=" In this paper, we summarize the classification of efflux transporters, the main metabolizing enzymes CYP3A, clinical significance interactions mediated by efflux transporters and CYP450 enzymes and in vitro studies" /><sentence text="" /></document>